Chimeric Antigen Receptor (CAR) T Cell Therapy for Malignant Pleural Mesothelioma (MPM) by Astero Klampatsa, Andrew R. Haas, Edmund K. Moon, Steven M. Albelda

Get full text

Immune Checkpoint Inhibitor Uptake in Real-World Patients With Malignant Pleural Mesothelioma by Roger Y. Kim, MD, Nandita Mitra, PhD, Stephen J. Bagley, MD, MSCE, Melina E. Marmarelis, MD, MSCE, Andrew R. Haas, MD, PhD, Katharine A. Rendle, PhD, MSW, MPH, Anil Vachani, MD, MSCE

Get full text

Molecular analysis of the endobronchial stent microbial biofilm reveals bacterial communities that associate with stent material and frequent fungal constituents. by John E McGinniss, Ize Imai, Aurea Simon-Soro, Melanie C Brown, Vincent R Knecht, Laura Frye, Priyanka M Ravindran, Marisol I Dothard, Dylan A Wadell, Michael B Sohn, Hongzhe Li, Jason D Christie, Joshua M Diamond, Andrew R Haas, Anthony R Lanfranco, David M DiBardino, Frederic D Bushman, Ronald G Collman

Get full text

Plasma Genotyping at the Time of Diagnostic Tissue Biopsy Decreases Time-to-Treatment in Patients With Advanced NSCLC—Results From a Prospective Pilot Study by Jeffrey C. Thompson, MD, MTR, Charu Aggarwal, MD, MPH, Janeline Wong, BS, Vivek Nimgaonkar, BS, Wei-Ting Hwang, PhD, Michelle Andronov, BS, David M. Dibardino, MD, Christoph T. Hutchinson, MD, MA, Kevin C. Ma, MD, Anthony Lanfranco, MD, MS, Edmund Moon, MD, Andrew R. Haas, MD, PhD, Aditi P. Singh, MD, Christine A. Ciunci, MD, MSCE, Melina Marmarelis, MD, MSCE, Christopher D’Avella, MD, Justine V. Cohen, DO, Joshua M. Bauml, MD, Roger B. Cohen, MD, Corey J. Langer, MD, Anil Vachani, MD, MSCE, Erica L. Carpenter, MBA, PhD

Get full text